Jie Zhu

Dr. Jie Zhu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2021 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
JZJie Zhu
Jie Zhu
JWJingxiang Wang
Jingxiang Wang
XWXin Wang
Xin Wang
MGMingjing Gao
Mingjing Gao
BGBingbing Guo
Bingbing Guo
ZXZhengwei Xie
Zhengwei Xie

Verified
Journal Article
Open access
PDF file
MGMiaomiao Gao
Miaomiao Gao
JZJie Zhu
Jie Zhu
ZHZhuo Huang
Zhuo Huang
ZXZhengwei Xie
Zhengwei Xie
Lung squamous cell carcinoma (LUSC) is often diagnosed at the advanced stage with poor prognosis. The mechanisms of its pathogenesis and prognosis require urgent elucidation. This study was performed to screen potential biomarkers related to the occurrence, development and prognosis of LUSC to reveal unknown physiological and pathological processes. Using bioinformatics analysis, the lung squamous cell carcinoma microarray datasets from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases were analyzed to identify differentially expressed genes (DEGs). Furthermore, PPI and WGCNA network analysis were integrated to identify the key genes closely related to the process of LUSC development. In addition, survival analysis was performed to achieve a prognostic model that accomplished good prediction accuracy. Three hundred and thirty–seven up–regulated and 119 down-regulated genes were identified, in which four genes have been found to play vital roles in LUSC development, namely CCNA2, AURKA, AURKB, and FEN1. The prognostic model contained 5 genes, which were all detrimental to prognosis. The AUC of the established prognostic model for predicting the survival of patients at 1, 3, and 5 years was 0.692, 0.722, and 0.651 in the test data, respectively. In conclusion, this study identified several biomarkers of significant interest for additional investigation of the therapies and methods of prognosis of lung squamous cell carcinoma.

Verified
Journal Article
Open access
PDF file
LHLiting Huang
Liting Huang
JZJie Zhu
Jie Zhu
JZJie Zhu
Jie Zhu
PLPeifeng Li
Peifeng Li
SZSujie Zhu
Sujie Zhu
Colon cancer is a common and leading cause of death and malignancy worldwide. N6-methylation of adenosine (m6A) is the most common reversible mRNA modification in eukaryotes, and it plays a crucial role in various biological functions in vivo. Dysregulated expression and genetic changes of m6A regulators have been correlated with tumorigenesis, cancer cell proliferation, tumor microenvironment, and prognosis in cancers. This study used RNA-seq and colon cancer clinical data to explore the relationship between N6-methylation and colon cancer. Based on the seven m6A regulators related to prognosis, three molecular subgroups of colon cancer were identified. Surprisingly, we found that each subgroup had unique survival characteristics. We then identified three subtypes of tumors based on 299 m6A phenotype-related genes, and one subtype was characterized as an immunosuppressive tumor and patients in this subtype may be more suitable for immunotherapy than other subtypes. Finally, using m6A-related genes and clinical information from The Cancer Genome Atlas cohort, we constructed a prognosis model, and this model could be used to predict the prognosis of patients in clinics.

Verified
Journal Article
Open access
PDF file
JZJie Zhu
Jie Zhu
JZJie Zhu
Jie Zhu
ZXZhengwei Xie
Zhengwei Xie
Ferroptosis is a new type of programmed cell death, which occurs with iron dependence. Previous studies have showed that ferroptosis plays an important regulatory role in the occurrence and development of tumors. Colon cancer is one of the major morbidities and causes of mortality in the world. This study used RNA-seq and colon cancer clinical data to explore the relationship between ferroptosis-related genes and colon cancer. Based on the fifteen prognostic ferroptosis-related genes, two molecular subgroups of colon cancer were identified. Surprisingly, we also found cluster2 was characterized by lower mutation burden and expression of checkpoint genes, better survival, and higher expression of NOX1. Moreover, cluster2 has fewer BRAF mutations. We also found the expression of NOX1 is related to the status of BRAF. Finally, using 15 ferroptosis-related genes from The Cancer Genome Atlas cohort, we constructed a prognosis model, and this model may be used to predict the prognosis of patients in clinics.

4 July 2023 in iMeta
Verified
Journal Article
Open access
JZJie Zhu
Jie Zhu
JZJie Zhu
Jie Zhu
SBSuzhen Bi
Suzhen Bi
LHLiting Huang
Liting Huang
PWPeng Wu
Peng Wu
SZSu‐Jie Zhu
Su‐Jie Zhu
We used an integrated ensemble learning method to build a stable prediction model for severity in COVID-19 patients, which was validated in multicenter cohorts.

18 May 2020 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
JZJie Zhu
Jie Zhu
XTXinyu Tu
Xinyu Tu
WHWeiran Huang
Weiran Huang
YYYang Yang
Yang Yang
ZXZhengwei Xie
Zhengwei Xie
ZHZhuo Huang
Zhuo Huang